I have two groups - patients (n=60) and healthy controls (n=20), M:F appr 1:1 for now, I have half of the patients already. The distribution is such because the type of analysis (MLPA) and the disease (AML) do not really necessitate a 1:1 for both groups, healthy control samples are mainly needed for quality measures of MLPA (3 controls are enough per run with

More Dinnar Yahya's questions See All
Similar questions and discussions